Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma

Patients with glioblastoma have a very poor prognosis despite aggressive therapeutic strategies. Cytomegalovirus has been detected in >90% of glioblastoma tumors. This virus can affect tumor progression and may represent a novel glioblastoma therapy target. We report, here, a retrospective surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Stragliotto, Giuseppe, Pantalone, Mattia Russel, Rahbar, Afsar, Söderberg-Nauclér, Cecilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599902/
https://www.ncbi.nlm.nih.gov/pubmed/32987955
http://dx.doi.org/10.3390/microorganisms8101471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599902/
https://www.ncbi.nlm.nih.gov/pubmed/32987955
http://dx.doi.org/10.3390/microorganisms8101471

Ejemplares similares